205
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Targeted Covalent Inhibitors for Novel Therapeutics

ORCID Icon, , , ORCID Icon & ORCID Icon
Pages 1739-1741 | Received 17 Aug 2023, Accepted 22 Aug 2023, Published online: 04 Oct 2023
 

Author contributions

JY Zhang, WS Gao and YX Wang wrote the draft manuscript. B Yu and JB Chang revised the draft. B Yu, on behalf of all authors, submitted this manuscript. All authors have given approval to submission of the manuscript.

Financial disclosure

This work was supported by Natural Science Foundation of China (nos. 81973177 and 22277110), Natural Science Foundation of Henan Province (no. 222300420069) and Program for Science & Technology Innovation Talents in Universities of Henan Province (no. 21HASTIT045). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Writing disclosure

No writing assistance was utilized in the production of this manuscript.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 99.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 265.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.